LNAI
Lunai Bioworks Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.33
+2.42%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.11x
- Price / sales
- 504.44x
- Price / cash flow
- -2.01x
Enterprise value
- Enterprise value
- $8.8M
- EV / sales
- 421.17x
- EV / EBITDA
- -0.07x
- EV / EBIT
- -0.90x
- Market cap
- $10.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026